117 related articles for article (PubMed ID: 1466279)
21. Human plasma kininogens are identical with alpha-cysteine proteinase inhibitors. Evidence from immunological, enzymological and sequence data.
Müller-Esterl W; Fritz H; Machleidt W; Ritonja A; Brzin J; Kotnik M; Turk V; Kellermann J; Lottspeich F
FEBS Lett; 1985 Mar; 182(2):310-4. PubMed ID: 2579850
[TBL] [Abstract][Full Text] [Related]
22. Local production of kinins contributes to the endothelium dependent relaxations evoked by converting enzyme inhibitors in isolated arteries.
Mombouli JV; Illiano S; Vanhoutte PM
Agents Actions Suppl; 1992; 38 ( Pt 3)():186-95. PubMed ID: 1462858
[TBL] [Abstract][Full Text] [Related]
23. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography.
Cuerrier D; Moldoveanu T; Inoue J; Davies PL; Campbell RL
Biochemistry; 2006 Jun; 45(24):7446-52. PubMed ID: 16768440
[TBL] [Abstract][Full Text] [Related]
24. Canine plasma kininogen: evidence for the presence of two kininogens and purification of high molecular weight kininogen and characterization as multi-functional molecule.
Mashiko H; Takahashi H
Comp Biochem Physiol B Biochem Mol Biol; 1997 Aug; 117(4):535-43. PubMed ID: 9297798
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of calcium bound domain VI of calpain at 1.9 A resolution and its role in enzyme assembly, regulation, and inhibitor binding.
Lin GD; Chattopadhyay D; Maki M; Wang KK; Carson M; Jin L; Yuen PW; Takano E; Hatanaka M; DeLucas LJ; Narayana SV
Nat Struct Biol; 1997 Jul; 4(7):539-47. PubMed ID: 9228946
[TBL] [Abstract][Full Text] [Related]
26. Determinants of tissue kallikrein cleavage specificity in the limited proteolysis of kininogens.
Prado ES; Chao J; Chagas JR; Juliano MA; Juliano L
Agents Actions Suppl; 1992; 38 ( Pt 1)():74-81. PubMed ID: 1466305
[TBL] [Abstract][Full Text] [Related]
27. Insights on monoclonal antibodies to kininogens' heavy chain which influence kininogens' binding to platelets.
Jiang Y; Nawarawong W; Meloni FJ; Schmaier AH
Thromb Haemost; 1992 Aug; 68(2):143-8. PubMed ID: 1412158
[TBL] [Abstract][Full Text] [Related]
28. Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L.
Desmazes C; Galineau L; Gauthier F; Brömme D; Lalmanach G
Eur J Biochem; 2003 Jan; 270(1):171-8. PubMed ID: 12492488
[TBL] [Abstract][Full Text] [Related]
29. Kininogens in nasal secretions after allergen challenge.
Baumgarten CR; Naclerio RM; Togias AG; Lichtenstein LM; Norman PS; Proud D
Adv Exp Med Biol; 1986; 198 Pt B():189-92. PubMed ID: 2433913
[TBL] [Abstract][Full Text] [Related]
30. Structure and physiological function of calpains.
Sorimachi H; Ishiura S; Suzuki K
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):721-32. PubMed ID: 9396712
[TBL] [Abstract][Full Text] [Related]
31. Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain.
Díaz BG; Gross S; Assfalg-Machleidt I; Pfeiler D; Gollmitzer N; Gabrijelcic-Geiger D; Stubbs MT; Fritz H; Auerswald EA; Machleidt W
Biol Chem; 2001 Jan; 382(1):97-107. PubMed ID: 11258679
[TBL] [Abstract][Full Text] [Related]
32. Calpain and kininogen mediated inflammation.
Sasaki M; Kunimatsu M; Tada T; Nishimura J; Ma XJ; Ohkubo I
Biomed Biochim Acta; 1991; 50(4-6):499-508. PubMed ID: 1801715
[TBL] [Abstract][Full Text] [Related]
33. The cystatins: protein inhibitors of cysteine proteinases.
Turk V; Bode W
FEBS Lett; 1991 Jul; 285(2):213-9. PubMed ID: 1855589
[TBL] [Abstract][Full Text] [Related]
34. Regulation of Zn-alpha2-glycoprotein-mediated cell adhesion by kininogens and their derivatives.
Ogikubo O; Maeda T; Yamane T; Ohtsuka T; Ohkubo I; Takahashi S; Ohnishi S; Matsui N
Biochem Biophys Res Commun; 1998 Nov; 252(1):257-62. PubMed ID: 9813179
[TBL] [Abstract][Full Text] [Related]
35. Characterization of brain calpains.
Nilsson E; Karlsson JO
J Neurochem; 1986 Oct; 47(4):1086-90. PubMed ID: 3018157
[TBL] [Abstract][Full Text] [Related]
36. [Physiopathologic significance of the radioimmunologic determination of human kininogens].
Adam A; Damas J; Ers P; Albert A; Stas JL; Lecomte J
Pathol Biol (Paris); 1986 Jan; 34(1):19-24. PubMed ID: 2422622
[TBL] [Abstract][Full Text] [Related]
37. Human kininogens interact with M protein, a bacterial surface protein and virulence determinant.
Ben Nasr AB; Herwald H; Müller-Esterl W; Björck L
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):173-80. PubMed ID: 7826326
[TBL] [Abstract][Full Text] [Related]
38. Purification and characterization of m-calpain from the skeletal muscle of the amphibian Rana ridibunda.
Sargianos N; Gaitanaki C; Beis I
J Exp Zool; 1994 Jun; 269(2):95-105. PubMed ID: 8207386
[TBL] [Abstract][Full Text] [Related]
39. Kinin formation from T-kininogen by spleen acid kininogenases.
Yamafuji K; Matsuki Y
Adv Exp Med Biol; 1989; 247B():97-102. PubMed ID: 2610108
[No Abstract] [Full Text] [Related]
40. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 2: Studies on kinin formation in focal and perifocal brain tissue.
Maier-Hauff K; Baethmann AJ; Lange M; Schürer L; Unterberg A
J Neurosurg; 1984 Jul; 61(1):97-106. PubMed ID: 6563063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
